The International Stem Cell Initiative: Toward benchmarks for human embryonic stem cell research
Article Abstract:
The International Stem Cell Forum, founded in January 2003 and chaired by the Medical Research Council of the United Kingdom, is a group made up of representatives of medical research funding bodies from fifteen countries with the goal of promoting international collaboration and funding support for stem cell research. A total of 75 human embryonic stem (hES) cell lines are collected and a basic set of characterization studies are carried out on them under defined conditions.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Unnatural selection of cultured human ES cell?
Article Abstract:
Human embryonic stem (ES) cells have the potential to provide an indefinitely renewable source of a wide range of normal cell types for use in research and regenerative medicine. Human ES repeatedly developed specific karyotypic abnormalities in vitro when grown under established culture regimens.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Simpler and safer cell reprogramming
Article Abstract:
The formation of induced pluripotent stem (iPS) cells from mouse or human fibroblasts without using an oncogene is described. Such experiments establish that cell reprogramming process can occur by the action of a few genes.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Monsanto unaffected by merger halt? California votes for embryonic stem cell research. FDA panel recommends easing gene therapy trial limits
- Abstracts: Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Overcoming the gridlock in discovery research
- Abstracts: Clinical trial data: To disclose or not to disclose? Cancer biomarkers: A systems approach. Cancer trials get set for biomarkers
- Abstracts: The return of the biotech scorecard. PEGing biotech growth. How do your stocks really perform?
- Abstracts: The biological magic behind the bullets. Structure-based maximal affinity model predicts small-molecule druggability